CEO SUMMARY: Three new business strategies are moving ChromaVision into different segments of the laboratory testing marketplace. The company has built a new laboratory facility and will support local pathology groups with advanced diagnostic technology. It is also expanding its presence in the research and development area of pharmacodiagnostics, with an emphasis on oncology. PROFIT […]
ChromaVision Targets National AP Market
Automated cellular imaging technology will support company’s expansion
- By Robert Michel
- > From the Volume XI No. 12 - August 30, 2004 Issue
- Tags: aco, anatomic pathologist, Anatomic pathology, anatomic pathology services, cap, cellular imaging, clinical trials, companion diagnostic, Companion diagnostics, Diagnostic technology, diagnostics market, ehi, FDA Clearance, lab service, lab services, laboratories, laboratory service, laboratory staff, laboratory test, laboratory testing, molecular diagnostic, pathologists, Pathology group, pathology groups, pathology lab, pathology laboratories, pathology service, pathology services, roche molecular diagnostic, roche molecular diagnostics, specialty lab, specialty laboratories, the laboratory
